{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:49:28Z","timestamp":1791424168895,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071262"],"award-info":[{"award-number":["32071262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271329"],"award-info":[{"award-number":["32271329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22473041"],"award-info":[{"award-number":["22473041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ2042"],"award-info":[{"award-number":["2024JJ2042"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118505","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:09:14Z","timestamp":1790546954000},"page":"118505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["A conotoxin-derived peptide exerts anti-tumor effects in ovarian cancer associated with activation of JNK\/JunB signaling"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8656-2375","authenticated-orcid":false,"given":"Jiawei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangfei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-3753","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118505_b0005","doi-asserted-by":"crossref","unstructured":"F. Bray, et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 74, 229-263 (2024).","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.bcp.2026.118505_b0010","article-title":"Elevating cancer care standards worldwide: an analysis of global initiatives and progress","volume":"10","author":"Wiernik","year":"2024","journal-title":"JCO Global Oncol."},{"key":"10.1016\/j.bcp.2026.118505_b0015","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S1470-2045(24)00522-9","article-title":"Integrating cancer into crisis: a global vision for action from WHO and partners","volume":"26","author":"Casolino","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118505_b0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Force","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2026.118505_b0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118505_b0030","doi-asserted-by":"crossref","unstructured":"N.S. Wagle, et al., Cancer treatment and survivorship statistics, 2025. CA: A Cancer J. Clin., 75, 308-340 (2025).","DOI":"10.3322\/caac.70011"},{"key":"10.1016\/j.bcp.2026.118505_b0035","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2026.118505_b0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118505_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103464","article-title":"Peptide-based drug discovery: current status and recent advances","volume":"28","author":"Sharma","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118505_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153218","article-title":"Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial","volume":"70","author":"Saghatelyan","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118505_b0055","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118505_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13025","article-title":"Peptide\u2010based therapeutic cancer vaccine: current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bcp.2026.118505_b0065","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2174\/1568026619666190125161517","article-title":"Peptides as potential anticancer agents","volume":"19","author":"Aaghaz","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118505_b0070","article-title":"Peptide-driven strategies against lung cancer","volume":"366\u2013367","author":"Karankar","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118505_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.118505_b0080","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","article-title":"From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery","volume":"11","author":"Bordon","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118505_b0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/toxins11110666","article-title":"The diversity of venom: the importance of behavior and venom system morphology in understanding its ecology and evolution","volume":"11","author":"Schendel","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2026.118505_b0090","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","article-title":"Peptides as multifunctional players in cancer therapy","volume":"55","author":"Vadevoo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2026.118505_b0095","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/jcm13061644","article-title":"A benefit\/risk assessment of intrathecal ziconotide in chronic pain: a narrative review","volume":"13","author":"Rubiu","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2026.118505_b0100","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867043363884","article-title":"Ziconotide: neuronal calcium channel blocker for treating severe chronic pain","volume":"11","author":"Miljanich","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118505_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","article-title":"Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy","volume":"402","author":"Rady","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118505_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117385","article-title":"Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom","volume":"179","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118505_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156367","article-title":"Melittin suppresses ovarian cancer growth by regulating SREBP1-mediated lipid metabolism","volume":"137","author":"Wu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118505_b0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxicon.2019.06.220","article-title":"Cytotoxicity of Nubein6. 8 peptide isolated from the snake venom of Naja nubiae on melanoma and ovarian carcinoma cell lines","volume":"168","author":"Abdel-Ghani","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2026.118505_b0125","article-title":"Pharmacological significance of the non-canonical NF-\u03baB pathway in tumorigenesis. Biochimica et Biophysica Acta (BBA)-Reviews on","volume":"1874","author":"Morgan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2026.118505_b0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/02648725.2022.2082157","article-title":"Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs","volume":"39","author":"Lath","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.bcp.2026.118505_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105327","article-title":"Venom peptides in cancer therapy: an updated review on cellular and molecular aspects","volume":"164","author":"Mirzaei","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.118505_b0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nature Cancer"},{"key":"10.1016\/j.bcp.2026.118505_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138880","article-title":"Discovery of anticancer peptides from natural and generated sequences using deep learning","volume":"290","author":"Yue","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2026.118505_b0150","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1021\/bi700775p","article-title":"Conolysin-Mt: a conus peptide that disrupts cellular membranes","volume":"46","author":"Biggs","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118505_b0155","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118505_b0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118505_b0165","first-page":"396","article-title":"Pathological roles of MAPK signaling pathways in human diseases","author":"Kim","year":"1802","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.bcp.2026.118505_b0170","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41388-018-0582-8","article-title":"The ERK and JNK pathways in the regulation of metabolic reprogramming","volume":"38","author":"Papa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118505_b0175","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.3390\/ijms23073847","article-title":"Metastasis and MAPK pathways","volume":"23","author":"Kciuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118505_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145998","article-title":"How vitamin E and its derivatives regulate tumour cells via the MAPK signalling pathway?'","volume":"808","author":"Yu","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2026.118505_b0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/cas.16389","article-title":"GADD45\u03b2-MTK1 signaling axis mediates oncogenic stress-induced activation of the p38 and JNK pathways","volume":"116","author":"Kawataki","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2026.118505_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2026.118505_b0195","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006072","article-title":"Cell signaling and stress responses","volume":"8","author":"Hotamisligil","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2026.118505_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom14020243","article-title":"The role of the dysregulated JNK signaling pathway in the pathogenesis of human diseases and its potential therapeutic strategies: a comprehensive review","volume":"14","author":"Yan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118505_b0205","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s12035-023-03209-x","article-title":"Stress-activated protein kinase JNK modulates depression-like behaviors in mice","volume":"60","author":"Zhou","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118505_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12672-025-01783-1","article-title":"Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance","volume":"16","author":"Xue","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bcp.2026.118505_b0215","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","volume":"20","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118505_b0220","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/1061186X.2021.1906885","article-title":"Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer","volume":"29","author":"Ciobanasu","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bcp.2026.118505_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114257","article-title":"Natural peptides for immunological regulation in cancer therapy: mechanism, facts and perspectives","volume":"159","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118505_b0230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.trecan.2017.07.004","article-title":"Venom peptides: improving specificity in cancer therapy","volume":"3","author":"Mahadevappa","year":"2017","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.bcp.2026.118505_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108344","article-title":"Efficient synthesis, stability-guided optimization and anticancer evaluation of bee venom peptide melittin","volume":"159","author":"Liu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2026.118505_b0240","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1021\/acsami.1c03640","article-title":"Delivery strategies for melittin-based cancer therapy","volume":"13","author":"Zhou","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2026.118505_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107430","article-title":"The therapeutic potential of bee venom-derived Apamin and Melittin conjugates in cancer treatment: a systematic review","volume":"209","author":"Laurindo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.118505_b0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2024.08.047","article-title":"Melittin-incorporated nanomedicines for enhanced cancer immunotherapy","volume":"375","author":"Duan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118505_b0255","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1093\/nar\/gkaa757","article-title":"Ribosomal stress-surveillance: three pathways is a magic number","volume":"48","author":"Vind","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118505_b0260","first-page":"2603","article-title":"Cellular stress response and apoptosis in cancer therapy","volume":"98","author":"Herr","year":"2001","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"10.1016\/j.bcp.2026.118505_b0265","first-page":"697","article-title":"Carfilzomib activates ER stress and JNK\/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells","volume":"56","author":"Deng","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bcp.2026.118505_b0270","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13843","article-title":"Chronic intermittent hypoxia-induced oxidative stress activates TRB3 and phosphorylated JNK to mediate insulin resistance and cell apoptosis in the pancreas","volume":"51","author":"Zeng","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2026.118505_b0275","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12272-025-01566-w","article-title":"Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosis","volume":"48","author":"Bhujbal","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118505_b0280","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118505_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1222265","article-title":"JunB: a paradigm for Jun family in immune response and cancer","volume":"13","author":"Ren","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2026.118505_b0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.1401595","article-title":"JUNB is a key transcriptional modulator of macrophage activation","volume":"194","author":"Fontana","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118505_b0295","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/cdd.2010.22","article-title":"Jun and JunD-dependent functions in cell proliferation and stress response","volume":"17","author":"Meixner","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118505_b0300","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.21873\/anticanres.18166","article-title":"Prognostic relevance of FOS and JUN family members and immune cell infiltration for the survival of patients with ovarian carcinoma","volume":"46","author":"Dawood","year":"2026","journal-title":"Anticancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:50:35Z","timestamp":1791420635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S0006295226008476"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118505","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A conotoxin-derived peptide exerts anti-tumor effects in ovarian cancer associated with activation of JNK\/JunB signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118505"}}